Wenshan District

Researchers are investigating calcific tendinitis of the shoulder, a painful condition affecting mainly adults between 30 and 60 years old characterized by calcium deposits in shoulder tendons. This trial aims to compare the effectiveness of real-time ultrasound-guided Extracorporeal Shock Wave Therapy ESWT versus conventional landmark-based methods in treating this condition. The study will enroll 60 patients confirmed to have calcific tendinitis and will be conducted as a randomized, double-blind controlled trial. Participants will be randomly assigned to one of two groups one receiving ESWT targeted using ultrasound imaging to precisely locate calcium deposits, and the other receiving ESWT guided by palpation and patient feedback. Both groups will receive shock wave therapy with energy levels between 0.12 to 0.25 mJmm applied 6000 times per session. The study will monitor patients over 12 weeks with assessments at baseline, 4 weeks, and 12 weeks after treatment. During the trial, participants will undergo evaluations including pain scoring, shoulder function tests, and ultrasound imaging to measure changes in calcific deposit size and tendon health. Primary outcomes measured are the Constant-Murley Score and Visual Analog Scale for pain, while secondary measures include shoulder range of motion, tendon structural integrity, and patient impression of change. The study emphasizes precise treatment delivery and aims to provide evidence to improve ESWT protocols for better patient outcomes.